Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.

Ide M, Ohnishi T, Murayama M, Matsumoto I, Yamada K, Iwayama Y, Dedova I, Toyota T, Asada T, Takashima A, Yoshikawa T.

J Neurochem. 2006 Oct;99(1):277-87.

2.

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA.

Nat Genet. 2004 Feb;36(2):131-7. Epub 2004 Jan 25.

PMID:
14745448
3.

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.

Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, O'Neill FA, Walsh D, Van den Oord EJ, Kendler KS, Riley BP.

Biol Psychiatry. 2008 Mar 1;63(5):449-57. Epub 2007 Sep 6.

4.
5.

Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease.

Willi R, Harmeier A, Giovanoli S, Meyer U.

Neuropharmacology. 2013 Oct;73:56-65. doi: 10.1016/j.neuropharm.2013.05.012. Epub 2013 May 21.

PMID:
23707483
6.

DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Blasi G, Napolitano F, Ursini G, Taurisano P, Romano R, Caforio G, Fazio L, Gelao B, Di Giorgio A, Iacovelli L, Sinibaldi L, Popolizio T, Usiello A, Bertolino A.

Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1158-63. doi: 10.1073/pnas.1013535108. Epub 2010 Dec 27.

7.

Association of AKT1 haplotype with the risk of schizophrenia in Iranian population.

Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, Fayyazi MR, Sargolzaee MR, Bajestan MN, Sabouri Z, Khayami E, Haghighi S, Hashemi SB, Eiraku N, Tufani H, Najmabadi H, Arimura K, Sano A, Osame M.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):383-6.

PMID:
16583435
8.

Photoactivation of Akt1/GSK3β Isoform-Specific Signaling Axis Promotes Pancreatic β-Cell Regeneration.

Huang L, Jiang X, Gong L, Xing D.

J Cell Biochem. 2015 Aug;116(8):1741-54. doi: 10.1002/jcb.25133.

PMID:
25736682
9.

[Regulation of PI3K-Akt-GSK3β signaling pathway in U251 cells by risperidone].

Liang L, Wang Y, Wei J, Gu X, Xiang B, Ma X, Li T.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Dec;31(6):693-7. doi: 10.3760/cma.j.issn.1003-9406.2014.06.003. Chinese.

PMID:
25449069
10.

Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.

Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE.

J Neurosci. 2008 Mar 5;28(10):2624-32. doi: 10.1523/JNEUROSCI.5245-07.2008.

11.

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.

Amar S, Shaltiel G, Mann L, Shamir A, Dean B, Scarr E, Bersudsky Y, Belmaker RH, Agam G.

Int J Neuropsychopharmacol. 2008 Mar;11(2):197-205. Epub 2007 Aug 6.

PMID:
17681085
12.

Pkb/Akt1 mediates Wnt/GSK3β/β-catenin signaling-induced apoptosis in human cord blood stem cells exposed to organophosphate pesticide monocrotophos.

Kashyap MP, Singh AK, Kumar V, Yadav DK, Khan F, Jahan S, Khanna VK, Yadav S, Pant AB.

Stem Cells Dev. 2013 Jan 15;22(2):224-38. doi: 10.1089/scd.2012.0220. Epub 2012 Aug 16.

13.

Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population.

Liu YL, Fann CS, Liu CM, Wu JY, Hung SI, Chan HY, Chen JJ, Pan CC, Liu SK, Hsieh MH, Hwang TJ, Ouyang WC, Chen CY, Lin JJ, Chou FH, Chueh CM, Liu WM, Tsuang MM, Faraone SV, Tsuang MT, Chen WJ, Hwu HG.

Psychiatr Genet. 2006 Feb;16(1):39-41.

PMID:
16395129
14.

Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal.

Bechard M, Dalton S.

Mol Cell Biol. 2009 Apr;29(8):2092-104. doi: 10.1128/MCB.01405-08. Epub 2009 Feb 17.

15.

No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.

Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Ozaki N.

Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):90-2.

PMID:
15719395
16.

P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.

Neary JT, Kang Y.

J Neurosci Res. 2006 Aug 15;84(3):515-24.

PMID:
16810687
17.

Association analysis of AKT1 and schizophrenia in a UK case control sample.

Norton N, Williams HJ, Dwyer S, Carroll L, Peirce T, Moskvina V, Segurado R, Nikolov I, Williams NM, Ikeda M, Iwata N, Owen MJ, O'Donovan MC.

Schizophr Res. 2007 Jul;93(1-3):58-65. Epub 2007 Mar 26.

PMID:
17383860
18.

Ser9-phosphorylated GSK3β induced by 14-3-3ζ actively antagonizes cell apoptosis in a NF-κB dependent manner.

Gao X, He Y, Gao LM, Feng J, Xie Y, Liu X, Liu L.

Biochem Cell Biol. 2014 Oct;92(5):349-56. doi: 10.1139/bcb-2014-0065. Epub 2014 Jul 17.

PMID:
25138042
19.

Paliperidone protects SK-N-SH cells against glutamate toxicity via Akt1/GSK3β signaling pathway.

Peng L, Zhang X, Cui X, Zhu D, Wu J, Sun D, Yue Q, Li Z, Liu H, Li G, Zhang J, Xu H, Liu F, Qin C, Li M, Sun J.

Schizophr Res. 2014 Aug;157(1-3):120-7. doi: 10.1016/j.schres.2014.05.037. Epub 2014 Jun 22.

PMID:
24962437
20.

Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia.

Hino M, Kunii Y, Matsumoto J, Wada A, Nagaoka A, Niwa S, Takahashi H, Kakita A, Akatsu H, Hashizume Y, Yamamoto S, Yabe H.

J Psychiatr Res. 2016 Nov;82:100-8. doi: 10.1016/j.jpsychires.2016.07.018. Epub 2016 Jul 25.

PMID:
27484635

Supplemental Content

Support Center